302 related articles for article (PubMed ID: 10527957)
1. Acute effects of LDL-apheresis on cholesterol oxidation products and antioxidants in plasma and lipoproteins of patients with familial hypercholesterolemia.
Linseisen J; Wilhelm M; Hoffmann J; Hailer S; Keller C; Wolfram G
Eur J Med Res; 1999 Oct; 4(10):433-41. PubMed ID: 10527957
[TBL] [Abstract][Full Text] [Related]
2. Acute and long-term effects of low-density lipoprotein (LDL)-apheresis on oxidative damage to LDL and reducing capacity of erythrocytes in patients with severe familial hypercholesterolaemia.
Stefanutti C; Di Giacomo S; Vivenzio A; Isacchi GC; Masella R; Caprari P; Varì R; Tarzia A; Mosiello A; Cantafora A
Clin Sci (Lond); 2001 Feb; 100(2):191-8. PubMed ID: 11171288
[TBL] [Abstract][Full Text] [Related]
3. [The plasma antioxidant status and trace elements in patients with familial hypercholesterolemia treated with LDL-apheresis].
Delattre J; Lepage S; Jaudon MC; Bruckert E; Assogba U; Bonnefont-Rousselot D
Ann Pharm Fr; 1998; 56(1):18-25. PubMed ID: 9770031
[TBL] [Abstract][Full Text] [Related]
4. Effects of LDL-immunoapheresis on plasma concentrations of vitamin E and carotenoids in patients with familial hypercholesterolemia.
Cauza E; Jansen M; Resch U; Dunky A; Derfler K; Winklhofer-Roob BM; Kostner K
J Clin Apher; 2004; 19(4):174-9. PubMed ID: 15597350
[TBL] [Abstract][Full Text] [Related]
5. Low density lipoprotein-apheresis decreases oxidized low density lipoproteins and monocyte adhesion to endothelial cells.
Cattin L; Petrucco A; Cazzolato G; Bon GB; Borelli V; Nardon E; Zabucchi G; Fonda M; Bordin P
ASAIO J; 1997; 43(3):209-13. PubMed ID: 9152493
[TBL] [Abstract][Full Text] [Related]
6. [LDL oxidation in homozygous familial hypercholesterolemia: effects of selective LDL-apheresis treatment].
Napoli C; Postiglione A; Scarpato N; Corso G; Ambrosio G; Condorelli M; Mancini M; Chiariello M
Cardiologia; 1996 May; 41(5):435-9. PubMed ID: 8767632
[TBL] [Abstract][Full Text] [Related]
7. The first results demonstrating efficiency and safety of a double-column whole blood method of LDL-apheresis.
Hequet O; Le QH; Rigal D; Mekhloufi F; Jaeger S; Sassolas A; Groisne L; Moulin P
Transfus Apher Sci; 2010 Feb; 42(1):3-10. PubMed ID: 19932056
[TBL] [Abstract][Full Text] [Related]
8. Coronary atherosclerosis reduced in patients with familial hypercholesterolemia after intensive cholesterol lowering with low-density lipoprotein-apheresis: 1-year follow-up study. The Osaka LDL-Apheresis Multicenter Trial Group.
Kitabatake A; Sato H; Hori M; Kamada T; Kubori S; Hoki N; Minamino T; Yamada M; Kato T
Clin Ther; 1994; 16(3):416-28. PubMed ID: 7923308
[TBL] [Abstract][Full Text] [Related]
9. [H.E.L.P. apheresis and oxidative stress].
Pulawski E; Mellwig KP; Horstkotte D
Z Kardiol; 2003; 92(Suppl 3):III38-41. PubMed ID: 14663600
[TBL] [Abstract][Full Text] [Related]
10. One year experience with a low density lipoprotein apheresis system.
Durst R; Rund D; Schurr D; Eliav O; Ben-Yehuda D; Shpizen S; Ben-Avi L; Schaap T; Pelz I; Leitersdorf E
Isr Med Assoc J; 2002 Sep; 4(9):677-80. PubMed ID: 12440228
[TBL] [Abstract][Full Text] [Related]
11. Comparison of different low density lipoprotein apheresis machines on brain natriuretic Peptide levels in patients with familial hypercholesterolemia.
Moriarty P; Sosland R; Gibson C; Belmont J
Ther Apher Dial; 2010 Feb; 14(1):74-8. PubMed ID: 20438521
[TBL] [Abstract][Full Text] [Related]
12. [Serum lipoprotein (a) levels during treatment with LDL apheresis for homozygous familial hypercholesterolemia].
Lasunción MA; Teruel JL; Alvarez JJ; Gómez-Coronado D; Ortuño J; Herrera E
Med Clin (Barc); 1992 Oct; 99(14):541-4. PubMed ID: 1434990
[TBL] [Abstract][Full Text] [Related]
13. Apheresis technologies for prevention and regression of atherosclerosis: clinical results.
Bambauer R; Schneidewind JM; Latza R
ASAIO J; 1999; 45(5):403-7. PubMed ID: 10503615
[TBL] [Abstract][Full Text] [Related]
14. Direct adsorption of lipoproteins (DALI) from whole blood: first long-term clinical experience with a new LDL-apheresis system for the treatment of familial hypercholesterolaemia.
Jansen M; Banyai S; Schmaldienst S; Goldammer A; Rohac M; Hörl WH; Derfler K
Wien Klin Wochenschr; 2000 Jan; 112(2):61-9. PubMed ID: 10703153
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of homozygous familial hypercholesterolemia with LDL-apheresis on a 4-year-old child].
Lefort B; Giraud C; Saulnier JP; Bott L; Gambert C; Sosner P; Hankard R
Arch Pediatr; 2009 Dec; 16(12):1554-8. PubMed ID: 19766469
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of LDL apheresis in patients with severe hypercholesterolemia.
Sachais BS; Katz J; Ross J; Rader DJ
J Clin Apher; 2005 Dec; 20(4):252-5. PubMed ID: 15880364
[TBL] [Abstract][Full Text] [Related]
17. [Biological efficacy of LDL apheresis in major hypercholesterolemia].
Dairou F; Assogba U; Bruckert E; De Gennes JL; Turpin G
Ann Med Interne (Paris); 1994; 145(5):328-32. PubMed ID: 7985942
[TBL] [Abstract][Full Text] [Related]
18. LDL-apheresis decreases plasma levels and urinary excretion of 8-epi-PGF2alpha.
Oguogho A; Ferlitsch A; Sinzinger H
Prostaglandins Leukot Essent Fatty Acids; 2000 Apr; 62(4):209-16. PubMed ID: 10882184
[TBL] [Abstract][Full Text] [Related]
19. [LDL apheresis--an effective treatment of homozygous familial hypercholesterolemia].
Kauppinen-Mäkelin R; Koivisto V; Virtanen KS; Taskinen MR; Miettinen T
Duodecim; 1990; 106(21):1465-70. PubMed ID: 1364677
[No Abstract] [Full Text] [Related]
20. The Effect of LDL-Apheresis and Rheohaemapheresis Treatment on Vitamin E.
Solichová D; Bláha M; Aufartová J; Krcmová LK; Plíšek J; Honegrová B; Kasalová E; Lánská M; Urbánek L; Sobotka L
J Nutr Sci Vitaminol (Tokyo); 2015; 61(2):105-12. PubMed ID: 26052140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
